Skip to main content

Disseminated Intravascular Coagulation and Thrombocytopenia

  • Chapter
  • First Online:
ICU Protocols
  • 1438 Accesses

Abstract

A 40-year-old male patient was admitted with acute pancreatitis. He developed fever, tachycardia, hypotension, and respiratory distress on the 3rd day of admission. His abdomen was severely tender and distended. Next morning the nurse noticed excessive oozing from arterial and central line insertion site, and his abdomen was further distended.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Alessandro Squizzato UOC, Medicina I. Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thromb Haemost. 2016;115(5):896–904. A review article which provide evidence and expert-based recommendations on the optimal supportive haemostatic and antithrombotic treatment strategies for patients with DIC based on five relevant clinical scenarios explained by international experts

    Article  Google Scholar 

  • Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol. 2008;124:567–76. A very good review on pathogenesis of DIC

    Article  Google Scholar 

  • Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145:24–33. are evidence-based guidelines diagnosis and management of DIC

    Article  CAS  Google Scholar 

  • Napolitano LM, Warkentin TE. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Crit Care Med. 2006;34(12):2898–911. This review article summarizes the pathogenesis and clinical consequences of HIT, describes the diagnostic process, and reviews currently available treatment options

    Article  CAS  Google Scholar 

  • Rice TW, Wheeler AP. Coagulopathy in critically ill patients: part 1: platelet disorders. Chest. 2009;136(6):1622–30. This article reviews the most frequent causes of thrombocytopenia by providing an overview of the following most common mechanisms: impaired production, sequestration, dilution, and destruction. Guidelines for treating thrombocytopenia and platelet dysfunction are also provided

    Article  Google Scholar 

  • Thachil J. Disseminated intravascular coagulation a practical approach. Anesthesiology. 2016;125:230–6. A practitioner guide for the management of DIC

    Article  Google Scholar 

  • Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients? Br J Haematol. 2017;177:27–38. A review of an approach to thrombocytopenia

    Article  Google Scholar 

  • Toh CH, Alhamdi Y, Abrams ST. Current pathological and laboratory considerations in the diagnosis of disseminated intravascular coagulation. Ann Lab Med. 2016;36(6):505–12. This is a concise review article that provide a practical diagnostic tool for acute DIC, a composite scoring system using rapidly available coagulation tests. Its usefulness and limitations are discussed alongside the advances and unanswered questions in DIC pathogenesis

    Article  CAS  Google Scholar 

  • Vincent JL, Francois B, Zabolotskikh I. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA. 2019;321(20):1993–2002. Randomised controlled trial of patients with sepsis-associated coagulopathy were randomized and treated with an intravenous bolus or a 15-minute infusion of thrombomodulin (0.06 mg/kg/d [maximum, 6 mg/d]; n = 395) or matching placebo (n = 405) once daily for 6 days. The primary end point was 28-day all-cause mortality. 28-day all-cause mortality rate was not statistically significantly different between the thrombomodulin group and the placebo group. The incidence of major bleed was somewhat higher in the thrombomodulin group

    Article  CAS  Google Scholar 

Website

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patil, V., Amin, N., Ambulkar, R., Kulkarni, A. (2020). Disseminated Intravascular Coagulation and Thrombocytopenia. In: Chawla, R., Todi, S. (eds) ICU Protocols. Springer, Singapore. https://doi.org/10.1007/978-981-15-0902-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0902-5_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0901-8

  • Online ISBN: 978-981-15-0902-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics